This success has led to the expansion of the Milan Criteria, which solely relies on the primary tumor size and number of nodules to determine whether a patient with HCC is eligible for LT and to also include other criteria, such as alpha-fetoprotein levels [12]. Here, AFP is linked to hepatocellular carcinoma.